Sci & Tech● Low1h ago · Nov 12, 2026, 1:24 AM
Miro clears TGA audit ahead of Crohn’s disease trial
GlobeAlert Desk · curated from Sydney Morning Herald · Australia · Oceania
Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Sci & Tech
Not flagged as developing.
More from Australia
Business1h agoAdidas to open first Australian airport store in BrisbaneSydney Morning Herald · AustraliaSci & Tech2h agoCan Southeast Asia cut and paste Australia’s AI safeguards?South China Morning PostPolitics3h agoShould Australia spend $32,000 on coffees for COP? Why Turnbull says yesSydney Morning Herald · AustraliaMilitary9h agoAustralian Army’s littoral transformation is the right move, experts sayBreaking Defense
More in Sci & Tech
Sci & Tech23m agoPope Leo XIV speaks about artificial intelligence in Peru and calls for protecting people from its consequencesInfobae · ArgentinaSci & Tech41m agoNTR Health University scrutinises 1,622 applications for UG research programmeThe HinduSci & Tech1h agoFrancis Ford Coppola defends human judgment in cinema against AI in MexicoInfobae · ArgentinaSci & Tech1h agoChina has more than 20 small nuclear reactor start-ups. Should the US worry?South China Morning Post